Skip to main navigation Skip to search Skip to main content

Repaglinide--a new compound for the treatment of patients with type 2 diabetes.

  • B.H.R. Wolffenbuttel*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Repaglinide--a new compound for the treatment of patients with type 2 diabetes.'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science